A friend who is fairly knowledgeable about running Trials was kind enough to have a look over this announcement and give a brief opinion of the announcement... Whilst not in any way familiar with NEU...
They thought the Biomarkers would be very useful in reducing costs and time in any Phase 3 trials....
And the the "reduced mortality" should be shouted from the roof tops...
Maybe NEU plan to do that.. They might get out on the hustings and talk this up soon enough...
A friend who is fairly knowledgeable about running Trials was...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$21.27 |
Change
0.650(3.15%) |
Mkt cap ! $2.718B | |||
| Open | High | Low | Value | Volume |
| $20.84 | $21.56 | $20.76 | $7.760M | 364.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1378 | $21.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $21.29 | 218 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| NEU (ASX) Chart |